McGuire, Darren K.
D’Alessio, David
Nicholls, Stephen J.
Nissen, Steven E.
Riesmeyer, Jeffrey S.
Pavo, Imre
Sethuraman, Shanthi
Heilmann, Cory R.
Kaiser, John J.
Weerakkody, Govinda J.
Article History
Received: 17 May 2022
Accepted: 11 August 2022
First Online: 24 August 2022
Declarations
:
: Not applicable.
: Not applicable.
: DKM reports honoraria, advisory board, and clinical trial executive committee fees from Eli Lilly; fees for consultancy and/or clinical trial executive committee from Boehringer Ingelheim, Sanofi, Novo Nordisk, AstraZeneca, Lexicon, Eisai Inc., Esperion, Metavant, Applied Therapeutics, and Afimmune; clinical trial data monitoring committee fees from Janssen Research and Development LLC, CSL Behring, and GlaxoSmithKline; advisory committee and global advisory board fees from Novo Nordisk and Merck Sharpe and Dohme; and clinical trial scientific advisory committee fees from Pfizer. DD reports research grants and advisory fees from Eli Lilly; research grants from Merck; consulting fees from Intarcia and Sun Pharmaceuticals; and editorial fees from American Diabetes Association journals. SJN reports research support, consulting and personal fees from Eli Lilly; grants and personal fees from AstraZeneca, Amgen, CSL Behring, Esperion, and Sanofi-Regeneron; grants from Anthera, Cerenis, Resverlogix, Novartis, and InfraReDx; and personal fees from Akcea, Boehringer Ingelheim, Kowa, Merck, Takeda, Pfizer, and Novo Nordisk. SEN reports grants from Eli Lilly, AstraZeneca, Esperion Therapeutics, Amgen, and Novo Nordisk. Although SEN works closely with pharmaceutical companies on the development of new therapies for cardiovascular disease, he maintains a longstanding policy of requiring companies to donate all related honoraria directly to charity so that he receives neither income, nor a tax deduction. IP, SS, CRH, JJK and GJW are employees and stockholders of Eli Lilly and Company. JSR was an employee of Eli Lilly and Company.